Literature DB >> 14633881

Haplotype structure of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and its relationship to serum total bilirubin concentration in a male Korean population.

Chang-Seok Ki1, Kyung-A Lee, Soo-Youn Lee, Hee-Jin Kim, Sang Sun Cho, Jun-Hee Park, Seunghee Cho, Kwang Min Sohn, Jong-Won Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14633881     DOI： 10.1373/clinchem.2003.024174

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  14 in total

1.  Incidence of atazanavir-associated hyperbilirubinemia in Korean HIV patients: 30 months follow-up results in a population with low UDP-glucuronosyltransferase1A1*28 allele frequency.

Authors:  Pyoeng Gyun Choe; Wan Beom Park; Jin Su Song; Nak-Hyun Kim; Kyoung-Ho Song; Sang Won Park; Hong Bin Kim; Nam Joong Kim; Myoung-don Oh
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

2.  The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.

Authors:  Suad AlFadhli; Hassan Al-Jafer; Mays Hadi; Mashael Al-Mutairi; Rasheeba Nizam
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

Review 3.  New insights in bilirubin metabolism and their clinical implications.

Authors:  Eva Sticova; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

4.  Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events.

Authors:  Shouji Shimoyama
Journal:  World J Gastrointest Surg       Date:  2010-01-27

Review 5.  Gene polymorphisms and their role in epilepsy treatment and prognosis.

Authors:  Ortrud K Steinlein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-16       Impact factor: 3.000

6.  Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.

Authors:  J-C Jo; J-L Lee; M-H Ryu; H M Chang; M Kim; H J Lee; H-S Kim; J-G Shin; T-W Kim; Y-K Kang
Journal:  Br J Cancer       Date:  2012-04-19       Impact factor: 7.640

7.  Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.

Authors:  Sollip Kim; Yeo Min Yun; Hyo Jin Chae; Hyun Jung Cho; Misuk Ji; In Suk Kim; Kyung A Wee; Woochang Lee; Sang Hoon Song; Hye In Woo; Soo Youn Lee; Sail Chun
Journal:  Ann Lab Med       Date:  2017-03       Impact factor: 3.464

8.  Serum Total Bilirubin, not Cholelithiasis, is Influenced by UGT1A1 Polymorphism, Alpha Thalassemia and β(s) Haplotype: First Report on Comparison between Arab-Indian and African β(s) Genes.

Authors:  Said Y Alkindi; Anil Pathare; Shoaib Al Zadjali; Vinodhkumar Panjwani; Fauzia Wasim; Hammad Khan; Pradeep Chopra; Rajagopal Krishnamoorthy; Salam Alkindi
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-11-01       Impact factor: 2.576

9.  Distribution of selected gene polymorphisms of UGT1A1 in a Saudi population.

Authors:  Khalid M Alkharfy; Amal M Alghamdi; Khawla M Bagulb; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Saleh Al-Muhsen; Rabih Halwani; Mohammad K Parvez; Mohammed S Al-Dosari
Journal:  Arch Med Sci       Date:  2013-08-20       Impact factor: 3.318

10.  Molecular Analysis of the UGT1A1 Gene in Korean Patients with Crigler-Najjar Syndrome Type II.

Authors:  Jae Sung Ko; Ju Young Chang; Jin Soo Moon; Hye Ran Yang; Jeong Kee Seo
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.